An international group of scientists has demonstrated a new tool for personalized medicine that makes it possible to predict nearly any adverse reaction an individual might have to drugs. Rather than being based on genetic screening, which up to now has been the dominant approach to personalized medicine, the new test relies on profiling an individual's metabolic products. Called pharmaco-metabonomics, the technique involves screening urine for metabolites: small molecules that are involved in or produced by the metabolic processes that sustain an organism.
Technology Review: Emerging Technologies and their Impact
- ► 2013 (23)
- ► 2008 (24)
- ► 2007 (65)
- Computer model details future flu pandemic
- China clones mad cow-resistant calf
- Flu Pandemic: Not just health but the economy, stu...
- Studies Find Elusive Key to Cell Fate in Embryo
- pharmaco-metabonomics? A simple say to predict rug...
- Roche says Tamiflu 'Rapid Response Stockpile' read...
- Strange New Products: Penis Stretcher
- Is The IPO door for biotech & medical devices open...
- States battle for slice of biotech pie
- Scientists learn more about how viruses reproduce,...
- Finding Clues to Flu's Spread on the Way to Work
- Texas biotech company aims to clone 100 horses per...
- ▼ April (12)